Aetiology of chronic liver disease is a valuable factor for stratifying adverse outcomes of acute decompensation: prospective observational study

Acute decompensation (AD) is defined as the development of complications related to portal hypertension and liver dysfunction that affect the progression of chronic liver disease (CLD) or liver cirrhosis (LC). Variations exist in patient demographics and prognostic outcomes of AD based on the aetiol...

Full description

Saved in:
Bibliographic Details
Published in:Annals of medicine (Helsinki) Vol. 57; no. 1; p. 2428431
Main Authors: Kim, Jung Hee, Kim, Sung-Eun, Song, Do Seon, Kim, Hee Yeon, Yoon, Eileen L., Park, Ji Won, Kim, Tae Hyung, Jung, Young-Kul, Suk, Ki Tae, Yim, Hyung Joon, Kwon, Jung Hyun, Lee, Sung Won, Kang, Seong Hee, Kim, Moon Young, Jeong, Soung Won, Jang, Jae-Young, Yoo, Jeong Ju, Kim, Sang Gyune, Jin, Young-Joo, Cheon, Gab Jin, Kim, Byung Seok, Seo, Yeon Seok, Kim, Hyoungsu, Sinn, Dong Hyun, Chung, Woo Jin, Kim, Hwi Young, Lee, Han Ah, Nam, Seung Woo, Kim, In Hee, Kim, Ji Hoon, Chae, Hee Bok, Sohn, Joo Hyun, Cho, Ju Yeon, Kim, Yoon Jun, Yang, Jin Mo, Park, Jung Gil, Kim, Won, Cho, Hyun Chin, Kim, Dong Joon
Format: Journal Article
Language:English
Published: England Taylor & Francis 01.12.2025
Taylor & Francis Group
Subjects:
ISSN:0785-3890, 1365-2060, 1365-2060
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Acute decompensation (AD) is defined as the development of complications related to portal hypertension and liver dysfunction that affect the progression of chronic liver disease (CLD) or liver cirrhosis (LC). Variations exist in patient demographics and prognostic outcomes of AD based on the aetiology of CLD, encompassing LC. However, limited research has been conducted to analyse these discrepancies across aetiologies. The prospective Korean Acute-on-Chronic Liver Failure (KACLiF) cohort consisted of 1,501 patients who were hospitalized with AD of CLD from July 2015 to August 2018. In this study, we assess the clinical attributes and prognostic implications of AD with CLD/LC stratified by the aetiology. Among 1,501 patients, the mean age was 54.7 years old and 1,118 patients (74.5%) were men. The common events of AD were GI bleeding (35.3%) and jaundice (35.0%). There was a median follow-up of 8.0 months (1.0-16.0 months). The most common aetiology of CLD was alcohol (  = 1021), followed by viral hepatitis (  = 206), viral hepatitis with alcohol-related (  = 129), cryptogenic (  = 108) and autoimmune (  = 37). Viral hepatitis with alcohol-related CLD showed a poor liver function profile and a high frequency of acute-on-chronic liver failure (ACLF) [22.1% vs. 19.6% (alcohol CLD), 8.1% (viral CLD), 5.6% (autoimmune related CLD and 16.0% (cryptogenic CLD)] with worse adverse outcomes (mortality or liver transplantation) than other aetiologies. The difference in aetiology was a significant factor for 28-day adverse outcomes in multivariate analysis even in a high MELD score (≥15), which indicated poor baseline liver function and prognosis (  < 0.001). The aetiology of CLD constitutes a pivotal determinant influencing both short- and long-term adverse outcomes of AD in CLD, even among individuals presenting with elevated MELD scores. Notably, patients afflicted with viral hepatitis should exercise caution even in the consumption of modest quantities of alcohol that induced the exacerbations in the adverse outcomes associated with AD.
AbstractList Acute decompensation (AD) is defined as the development of complications related to portal hypertension and liver dysfunction that affect the progression of chronic liver disease (CLD) or liver cirrhosis (LC). Variations exist in patient demographics and prognostic outcomes of AD based on the aetiology of CLD, encompassing LC. However, limited research has been conducted to analyse these discrepancies across aetiologies.BACKGROUND/AIMSAcute decompensation (AD) is defined as the development of complications related to portal hypertension and liver dysfunction that affect the progression of chronic liver disease (CLD) or liver cirrhosis (LC). Variations exist in patient demographics and prognostic outcomes of AD based on the aetiology of CLD, encompassing LC. However, limited research has been conducted to analyse these discrepancies across aetiologies.The prospective Korean Acute-on-Chronic Liver Failure (KACLiF) cohort consisted of 1,501 patients who were hospitalized with AD of CLD from July 2015 to August 2018. In this study, we assess the clinical attributes and prognostic implications of AD with CLD/LC stratified by the aetiology.METHODSThe prospective Korean Acute-on-Chronic Liver Failure (KACLiF) cohort consisted of 1,501 patients who were hospitalized with AD of CLD from July 2015 to August 2018. In this study, we assess the clinical attributes and prognostic implications of AD with CLD/LC stratified by the aetiology.Among 1,501 patients, the mean age was 54.7 years old and 1,118 patients (74.5%) were men. The common events of AD were GI bleeding (35.3%) and jaundice (35.0%). There was a median follow-up of 8.0 months (1.0-16.0 months). The most common aetiology of CLD was alcohol (n = 1021), followed by viral hepatitis (n = 206), viral hepatitis with alcohol-related (n = 129), cryptogenic (n = 108) and autoimmune (n = 37). Viral hepatitis with alcohol-related CLD showed a poor liver function profile and a high frequency of acute-on-chronic liver failure (ACLF) [22.1% vs. 19.6% (alcohol CLD), 8.1% (viral CLD), 5.6% (autoimmune related CLD and 16.0% (cryptogenic CLD)] with worse adverse outcomes (mortality or liver transplantation) than other aetiologies. The difference in aetiology was a significant factor for 28-day adverse outcomes in multivariate analysis even in a high MELD score (≥15), which indicated poor baseline liver function and prognosis (p < 0.001).RESULTSAmong 1,501 patients, the mean age was 54.7 years old and 1,118 patients (74.5%) were men. The common events of AD were GI bleeding (35.3%) and jaundice (35.0%). There was a median follow-up of 8.0 months (1.0-16.0 months). The most common aetiology of CLD was alcohol (n = 1021), followed by viral hepatitis (n = 206), viral hepatitis with alcohol-related (n = 129), cryptogenic (n = 108) and autoimmune (n = 37). Viral hepatitis with alcohol-related CLD showed a poor liver function profile and a high frequency of acute-on-chronic liver failure (ACLF) [22.1% vs. 19.6% (alcohol CLD), 8.1% (viral CLD), 5.6% (autoimmune related CLD and 16.0% (cryptogenic CLD)] with worse adverse outcomes (mortality or liver transplantation) than other aetiologies. The difference in aetiology was a significant factor for 28-day adverse outcomes in multivariate analysis even in a high MELD score (≥15), which indicated poor baseline liver function and prognosis (p < 0.001).The aetiology of CLD constitutes a pivotal determinant influencing both short- and long-term adverse outcomes of AD in CLD, even among individuals presenting with elevated MELD scores. Notably, patients afflicted with viral hepatitis should exercise caution even in the consumption of modest quantities of alcohol that induced the exacerbations in the adverse outcomes associated with AD.CONCLUSIONThe aetiology of CLD constitutes a pivotal determinant influencing both short- and long-term adverse outcomes of AD in CLD, even among individuals presenting with elevated MELD scores. Notably, patients afflicted with viral hepatitis should exercise caution even in the consumption of modest quantities of alcohol that induced the exacerbations in the adverse outcomes associated with AD.
Background/Aims Acute decompensation (AD) is defined as the development of complications related to portal hypertension and liver dysfunction that affect the progression of chronic liver disease (CLD) or liver cirrhosis (LC). Variations exist in patient demographics and prognostic outcomes of AD based on the aetiology of CLD, encompassing LC. However, limited research has been conducted to analyse these discrepancies across aetiologies.Methods The prospective Korean Acute-on-Chronic Liver Failure (KACLiF) cohort consisted of 1,501 patients who were hospitalized with AD of CLD from July 2015 to August 2018. In this study, we assess the clinical attributes and prognostic implications of AD with CLD/LC stratified by the aetiology.Results Among 1,501 patients, the mean age was 54.7 years old and 1,118 patients (74.5%) were men. The common events of AD were GI bleeding (35.3%) and jaundice (35.0%). There was a median follow-up of 8.0 months (1.0–16.0 months). The most common aetiology of CLD was alcohol (n = 1021), followed by viral hepatitis (n = 206), viral hepatitis with alcohol-related (n = 129), cryptogenic (n = 108) and autoimmune (n = 37). Viral hepatitis with alcohol-related CLD showed a poor liver function profile and a high frequency of acute-on-chronic liver failure (ACLF) [22.1% vs. 19.6% (alcohol CLD), 8.1% (viral CLD), 5.6% (autoimmune related CLD and 16.0% (cryptogenic CLD)] with worse adverse outcomes (mortality or liver transplantation) than other aetiologies. The difference in aetiology was a significant factor for 28-day adverse outcomes in multivariate analysis even in a high MELD score (≥15), which indicated poor baseline liver function and prognosis (p < 0.001).Conclusion The aetiology of CLD constitutes a pivotal determinant influencing both short- and long-term adverse outcomes of AD in CLD, even among individuals presenting with elevated MELD scores. Notably, patients afflicted with viral hepatitis should exercise caution even in the consumption of modest quantities of alcohol that induced the exacerbations in the adverse outcomes associated with AD.
Acute decompensation (AD) is defined as the development of complications related to portal hypertension and liver dysfunction that affect the progression of chronic liver disease (CLD) or liver cirrhosis (LC). Variations exist in patient demographics and prognostic outcomes of AD based on the aetiology of CLD, encompassing LC. However, limited research has been conducted to analyse these discrepancies across aetiologies. The prospective Korean Acute-on-Chronic Liver Failure (KACLiF) cohort consisted of 1,501 patients who were hospitalized with AD of CLD from July 2015 to August 2018. In this study, we assess the clinical attributes and prognostic implications of AD with CLD/LC stratified by the aetiology. Among 1,501 patients, the mean age was 54.7 years old and 1,118 patients (74.5%) were men. The common events of AD were GI bleeding (35.3%) and jaundice (35.0%). There was a median follow-up of 8.0 months (1.0-16.0 months). The most common aetiology of CLD was alcohol (  = 1021), followed by viral hepatitis (  = 206), viral hepatitis with alcohol-related (  = 129), cryptogenic (  = 108) and autoimmune (  = 37). Viral hepatitis with alcohol-related CLD showed a poor liver function profile and a high frequency of acute-on-chronic liver failure (ACLF) [22.1% vs. 19.6% (alcohol CLD), 8.1% (viral CLD), 5.6% (autoimmune related CLD and 16.0% (cryptogenic CLD)] with worse adverse outcomes (mortality or liver transplantation) than other aetiologies. The difference in aetiology was a significant factor for 28-day adverse outcomes in multivariate analysis even in a high MELD score (≥15), which indicated poor baseline liver function and prognosis (  < 0.001). The aetiology of CLD constitutes a pivotal determinant influencing both short- and long-term adverse outcomes of AD in CLD, even among individuals presenting with elevated MELD scores. Notably, patients afflicted with viral hepatitis should exercise caution even in the consumption of modest quantities of alcohol that induced the exacerbations in the adverse outcomes associated with AD.
Author Kim, Sang Gyune
Kim, Ji Hoon
Kim, Jung Hee
Seo, Yeon Seok
Sinn, Dong Hyun
Kim, Dong Joon
Kim, Hwi Young
Kim, Yoon Jun
Cho, Hyun Chin
Kim, Tae Hyung
Kwon, Jung Hyun
Lee, Han Ah
Chae, Hee Bok
Kim, Won
Kim, Sung-Eun
Yoo, Jeong Ju
Yang, Jin Mo
Cheon, Gab Jin
Kim, Hyoungsu
Jang, Jae-Young
Jin, Young-Joo
Kim, Hee Yeon
Jung, Young-Kul
Kim, In Hee
Park, Ji Won
Jeong, Soung Won
Kang, Seong Hee
Song, Do Seon
Cho, Ju Yeon
Suk, Ki Tae
Kim, Moon Young
Nam, Seung Woo
Chung, Woo Jin
Yoon, Eileen L.
Kim, Byung Seok
Yim, Hyung Joon
Park, Jung Gil
Sohn, Joo Hyun
Lee, Sung Won
Author_xml – sequence: 1
  givenname: Jung Hee
  surname: Kim
  fullname: Kim, Jung Hee
  organization: Department of Internal Medicine, Hallym Medical Center, Hallym University College of Medicine, Chuncheon, Republic of Korea, Institute for Liver and Digestive Diseases, Hallym University, Chuncheon, Republic of Korea
– sequence: 2
  givenname: Sung-Eun
  surname: Kim
  fullname: Kim, Sung-Eun
  organization: Department of Internal Medicine, Hallym Medical Center, Hallym University College of Medicine, Chuncheon, Republic of Korea, Institute for Liver and Digestive Diseases, Hallym University, Chuncheon, Republic of Korea
– sequence: 3
  givenname: Do Seon
  surname: Song
  fullname: Song, Do Seon
  organization: Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
– sequence: 4
  givenname: Hee Yeon
  surname: Kim
  fullname: Kim, Hee Yeon
  organization: Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
– sequence: 5
  givenname: Eileen L.
  surname: Yoon
  fullname: Yoon, Eileen L.
  organization: Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea
– sequence: 6
  givenname: Ji Won
  surname: Park
  fullname: Park, Ji Won
  organization: Department of Internal Medicine, Hallym Medical Center, Hallym University College of Medicine, Chuncheon, Republic of Korea, Institute for Liver and Digestive Diseases, Hallym University, Chuncheon, Republic of Korea
– sequence: 7
  givenname: Tae Hyung
  surname: Kim
  fullname: Kim, Tae Hyung
  organization: Department of Internal Medicine, Korea University Medical Center, Seoul, Republic of Korea
– sequence: 8
  givenname: Young-Kul
  surname: Jung
  fullname: Jung, Young-Kul
  organization: Department of Internal Medicine, Korea University Medical Center, Seoul, Republic of Korea
– sequence: 9
  givenname: Ki Tae
  surname: Suk
  fullname: Suk, Ki Tae
  organization: Department of Internal Medicine, Hallym Medical Center, Hallym University College of Medicine, Chuncheon, Republic of Korea, Institute for Liver and Digestive Diseases, Hallym University, Chuncheon, Republic of Korea
– sequence: 10
  givenname: Hyung Joon
  surname: Yim
  fullname: Yim, Hyung Joon
  organization: Department of Internal Medicine, Korea University Medical Center, Seoul, Republic of Korea
– sequence: 11
  givenname: Jung Hyun
  surname: Kwon
  fullname: Kwon, Jung Hyun
  organization: Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
– sequence: 12
  givenname: Sung Won
  surname: Lee
  fullname: Lee, Sung Won
  organization: Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
– sequence: 13
  givenname: Seong Hee
  surname: Kang
  fullname: Kang, Seong Hee
  organization: Department of Internal Medicine, Korea University Medical Center, Seoul, Republic of Korea
– sequence: 14
  givenname: Moon Young
  surname: Kim
  fullname: Kim, Moon Young
  organization: Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea
– sequence: 15
  givenname: Soung Won
  surname: Jeong
  fullname: Jeong, Soung Won
  organization: Department of Internal Medicine, Soonchunhyang University College of Medicine, Seoul, Republic of Korea
– sequence: 16
  givenname: Jae-Young
  surname: Jang
  fullname: Jang, Jae-Young
  organization: Department of Internal Medicine, Soonchunhyang University College of Medicine, Seoul, Republic of Korea
– sequence: 17
  givenname: Jeong Ju
  surname: Yoo
  fullname: Yoo, Jeong Ju
  organization: Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Republic of Korea
– sequence: 18
  givenname: Sang Gyune
  surname: Kim
  fullname: Kim, Sang Gyune
  organization: Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Republic of Korea
– sequence: 19
  givenname: Young-Joo
  surname: Jin
  fullname: Jin, Young-Joo
  organization: Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine, Incheon, Republic of Korea
– sequence: 20
  givenname: Gab Jin
  surname: Cheon
  fullname: Cheon, Gab Jin
  organization: Department of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Republic of Korea
– sequence: 21
  givenname: Byung Seok
  surname: Kim
  fullname: Kim, Byung Seok
  organization: Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Republic of Korea
– sequence: 22
  givenname: Yeon Seok
  surname: Seo
  fullname: Seo, Yeon Seok
  organization: Department of Internal Medicine, Korea University Medical Center, Seoul, Republic of Korea
– sequence: 23
  givenname: Hyoungsu
  surname: Kim
  fullname: Kim, Hyoungsu
  organization: Department of Internal Medicine, Hallym Medical Center, Hallym University College of Medicine, Chuncheon, Republic of Korea, Institute for Liver and Digestive Diseases, Hallym University, Chuncheon, Republic of Korea
– sequence: 24
  givenname: Dong Hyun
  surname: Sinn
  fullname: Sinn, Dong Hyun
  organization: Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
– sequence: 25
  givenname: Woo Jin
  surname: Chung
  fullname: Chung, Woo Jin
  organization: Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Republic of Korea
– sequence: 26
  givenname: Hwi Young
  surname: Kim
  fullname: Kim, Hwi Young
  organization: Department of Internal Medicine, College of Medicine, Ewha Womans University, Seoul, Republic of Korea
– sequence: 27
  givenname: Han Ah
  surname: Lee
  fullname: Lee, Han Ah
  organization: Department of Internal Medicine, College of Medicine, Ewha Womans University, Seoul, Republic of Korea
– sequence: 28
  givenname: Seung Woo
  surname: Nam
  fullname: Nam, Seung Woo
  organization: Department of Internal Medicine, National Medical Center, Seoul, Republic of Korea
– sequence: 29
  givenname: In Hee
  surname: Kim
  fullname: Kim, In Hee
  organization: Department of Internal Medicine, Chonbuk National University Hospital, Chonbuk National University Medical School, Jeonju, Republic of Korea
– sequence: 30
  givenname: Ji Hoon
  surname: Kim
  fullname: Kim, Ji Hoon
  organization: Department of Internal Medicine, Korea University Medical Center, Seoul, Republic of Korea
– sequence: 31
  givenname: Hee Bok
  surname: Chae
  fullname: Chae, Hee Bok
  organization: Department of Internal Medicine, Medical Research Institute, Chungbuk National University College of Medicine, Cheongju, Republic of Korea
– sequence: 32
  givenname: Joo Hyun
  surname: Sohn
  fullname: Sohn, Joo Hyun
  organization: Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea
– sequence: 33
  givenname: Ju Yeon
  surname: Cho
  fullname: Cho, Ju Yeon
  organization: Department of Internal Medicine, College of Medicine, Chosun University, Gwangju, Republic of Korea
– sequence: 34
  givenname: Yoon Jun
  surname: Kim
  fullname: Kim, Yoon Jun
  organization: Department of Internal Medicine, Liver Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea
– sequence: 35
  givenname: Jin Mo
  surname: Yang
  fullname: Yang, Jin Mo
  organization: Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
– sequence: 36
  givenname: Jung Gil
  surname: Park
  fullname: Park, Jung Gil
  organization: Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Republic of Korea
– sequence: 37
  givenname: Won
  surname: Kim
  fullname: Kim, Won
  organization: Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Republic of Korea
– sequence: 38
  givenname: Hyun Chin
  surname: Cho
  fullname: Cho, Hyun Chin
  organization: Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Republic of Korea
– sequence: 39
  givenname: Dong Joon
  surname: Kim
  fullname: Kim, Dong Joon
  organization: Department of Internal Medicine, Hallym Medical Center, Hallym University College of Medicine, Chuncheon, Republic of Korea, Institute for Liver and Digestive Diseases, Hallym University, Chuncheon, Republic of Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39856091$$D View this record in MEDLINE/PubMed
BookMark eNpVkt9uFCEUh4mpsdvqI2i49GZWGP6ON6ZptG3SxBu9Jgxz2NKwwwozm-xj-MYy3W1jLwjJOR_fCfC7QGdjGgGhj5SsKdHkC1FaMN2RdUtavm55qzmjb9CKMimalkhyhlYL0yzQOboo5ZEQ0ipK3qFz1mkhSUdX6O8VTCHFtDng5LF7yGkMDsewh4yHUMAWwKFgi_c2zraPgL11U8rY11WmbKfgD2HcYDvUIxVO8-TSFsqis26eAA9QCzsYS2XT-BXvcio7cFOdgVNfIO-fGjZW3zwc3qO33sYCH077Jfr94_uv69vm_ufN3fXVfeN4K6emV6qXnDnuFadd67TUA-GDrhXufNdyWi-uSSekFEJIrnzv1EAZsZwBk4Rdorujd0j20exy2Np8MMkG81RIeWNsnoKLYDi3XvSuF04AF8T13LZeOnCKdXYQUF3fjq7d3G9hcDDWl4mvpK87Y3gwm7Q3lCpFtFDV8PlkyOnPDGUy21AcxGhHSHMxjIpOdVIrVtFP_w97mfL8qRUQR8DVly4Z_AtCiVnCY57DY5bwmFN42D_eYrqI
Cites_doi 10.1080/00365521.2020.1743751
10.1016/j.jhep.2018.12.008
10.1097/00003246-199711000-00014
10.1111/ajt.15559
10.1002/hep.31065
10.1002/lt.25443
10.1371/journal.pone.0146745
10.1053/j.gastro.2013.02.042
10.1155/2016/1329532
10.3350/cmh.2018.1004
10.1016/j.jhep.2014.11.012
10.1016/S2468-1253(19)30415-7
10.3748/wjg.v28.i41.5910
10.1136/gutjnl-2017-314641
10.1159/000451057
10.2147/HMER.S197933
10.1056/NEJMra1914900
10.1038/srep25487
10.14218/JCTH.2014.00030
10.1016/j.jhep.2016.11.011
10.1002/hep.28414
10.3350/cmh.2022.0084
10.1002/hep.27779
10.1007/s12072-019-09946-3
10.1016/S2468-1253(22)00050-4
10.3350/cmh.2013.19.3.216
10.1097/MOG.0000000000000434
10.1007/s10620-010-1390-3
10.1016/S0140-6736(08)60383-9
ContentType Journal Article
Copyright 2025 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2025 The Author(s)
Copyright_xml – notice: 2025 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2025 The Author(s)
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1080/07853890.2024.2428431
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate J. H. Kim et al
EISSN 1365-2060
ExternalDocumentID oai_doaj_org_article_44af5bcb5c5e450cb4a2f6cec739ad5e
PMC11770857
39856091
10_1080_07853890_2024_2428431
Genre Journal Article
Observational Study
GeographicLocations Republic of Korea
GeographicLocations_xml – name: Republic of Korea
GroupedDBID ---
00X
03L
0YH
23M
36B
4.4
5GY
5RE
AAFWJ
AALUX
AAYXX
ABLKL
ABUPF
ACGEJ
ACGFS
ADCVX
ADRBQ
ADXPE
AENEX
AEOZL
AFKVX
AFPKN
AGYJP
AIJEM
AJWEG
ALMA_UNASSIGNED_HOLDINGS
AQTUD
BABNJ
BLEHA
BOHLJ
CCCUG
CITATION
CS3
DKSSO
EBD
EBS
EMB
EMOBN
F5P
GROUPED_DOAJ
H13
HZ~
KRBQP
KSSTO
KWAYT
KYCEM
LJTGL
O9-
OK1
P2P
RPM
SV3
TDBHL
TFDNU
TFL
TFW
V1S
WH7
~1N
.55
.GJ
34G
39C
3O-
53G
5VS
AALIY
AAORF
AAPXX
ABWCV
ABZEW
ADFZZ
AFFNX
AFLEI
AJVHN
AWYRJ
BRMBE
CAG
CGR
COF
CUY
CVF
CYYVM
CZDIS
DRXRE
DWTOO
ECM
EIF
EJD
JENTW
M44
M4Z
NPM
NUSFT
OVD
QQXMO
TEORI
X7M
ZGI
ZXP
7X8
5PM
ID FETCH-LOGICAL-c426t-b77b643c4f74192c868d04d83c44cf9241389809566555647fbc7d130a43e3603
IEDL.DBID DOA
ISICitedReferencesCount 0
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001406236400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0785-3890
1365-2060
IngestDate Mon Nov 10 04:31:02 EST 2025
Tue Nov 04 02:03:38 EST 2025
Sat Sep 27 20:48:13 EDT 2025
Wed Jun 11 01:41:49 EDT 2025
Sat Nov 29 03:01:13 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords aetiology
Chronic liver disease
acute decompensation
liver cirrhosis
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c426t-b77b643c4f74192c868d04d83c44cf9241389809566555647fbc7d130a43e3603
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
Supplemental data for this article can be accessed online at https://doi.org/10.1080/07853890.2024.2428431.
OpenAccessLink https://doaj.org/article/44af5bcb5c5e450cb4a2f6cec739ad5e
PMID 39856091
PQID 3159796873
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_44af5bcb5c5e450cb4a2f6cec739ad5e
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11770857
proquest_miscellaneous_3159796873
pubmed_primary_39856091
crossref_primary_10_1080_07853890_2024_2428431
PublicationCentury 2000
PublicationDate 2025-Dec
PublicationDateYYYYMMDD 2025-12-01
PublicationDate_xml – month: 12
  year: 2025
  text: 2025-Dec
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Annals of medicine (Helsinki)
PublicationTitleAlternate Ann Med
PublicationYear 2025
Publisher Taylor & Francis
Taylor & Francis Group
Publisher_xml – name: Taylor & Francis
– name: Taylor & Francis Group
References e_1_3_6_30_1
e_1_3_6_31_1
Korean Association for the Study of the Liver (e_1_3_6_15_1) 2013; 19
e_1_3_6_32_1
e_1_3_6_11_1
e_1_3_6_10_1
Korean Association for the Study of the L (e_1_3_6_12_1) 2022; 28
Korean Association for the Study of the L (e_1_3_6_13_1) 2018; 24
e_1_3_6_14_1
e_1_3_6_19_1
e_1_3_6_18_1
e_1_3_6_17_1
e_1_3_6_20_1
e_1_3_6_21_1
e_1_3_6_22_1
e_1_3_6_2_1
Allen JP (e_1_3_6_16_1) 1995
e_1_3_6_6_1
e_1_3_6_5_1
e_1_3_6_4_1
e_1_3_6_3_1
e_1_3_6_9_1
e_1_3_6_8_1
e_1_3_6_7_1
Saab S (e_1_3_6_27_1) 2006; 4
e_1_3_6_28_1
e_1_3_6_29_1
e_1_3_6_23_1
e_1_3_6_24_1
e_1_3_6_25_1
e_1_3_6_26_1
References_xml – ident: e_1_3_6_24_1
  doi: 10.1080/00365521.2020.1743751
– ident: e_1_3_6_21_1
  doi: 10.1016/j.jhep.2018.12.008
– ident: e_1_3_6_17_1
  doi: 10.1097/00003246-199711000-00014
– ident: e_1_3_6_30_1
  doi: 10.1111/ajt.15559
– ident: e_1_3_6_14_1
  doi: 10.1002/hep.31065
– ident: e_1_3_6_31_1
  doi: 10.1002/lt.25443
– ident: e_1_3_6_7_1
  doi: 10.1371/journal.pone.0146745
– ident: e_1_3_6_3_1
  doi: 10.1053/j.gastro.2013.02.042
– ident: e_1_3_6_29_1
  doi: 10.1155/2016/1329532
– volume: 24
  start-page: 169
  issue: 3
  year: 2018
  ident: e_1_3_6_13_1
  article-title: 2017 KASL clinical practice guidelines management of hepatitis C: treatment of chronic hepatitis C
  publication-title: Clin Mol Hepatol
  doi: 10.3350/cmh.2018.1004
– ident: e_1_3_6_18_1
  doi: 10.1016/j.jhep.2014.11.012
– ident: e_1_3_6_25_1
  doi: 10.1016/S2468-1253(19)30415-7
– volume: 4
  start-page: 395
  issue: 1
  year: 2006
  ident: e_1_3_6_27_1
  article-title: The MELD score in advanced liver disease: association with clinical portal hypertension and mortality
  publication-title: Exp Clin Transplant
– ident: e_1_3_6_6_1
  doi: 10.3748/wjg.v28.i41.5910
– ident: e_1_3_6_8_1
  doi: 10.1136/gutjnl-2017-314641
– ident: e_1_3_6_20_1
  doi: 10.1159/000451057
– start-page: 1
  volume-title: Assessing alcohol problems: a guide for clinicians and researchers. NIAAA treatment handbook series 4 (NIH Publication No. 95-3745
  year: 1995
  ident: e_1_3_6_16_1
– ident: e_1_3_6_32_1
  doi: 10.2147/HMER.S197933
– ident: e_1_3_6_5_1
  doi: 10.1056/NEJMra1914900
– ident: e_1_3_6_9_1
  doi: 10.1038/srep25487
– ident: e_1_3_6_19_1
  doi: 10.14218/JCTH.2014.00030
– ident: e_1_3_6_23_1
  doi: 10.1016/j.jhep.2016.11.011
– ident: e_1_3_6_4_1
  doi: 10.1002/hep.28414
– volume: 28
  start-page: 276
  issue: 2
  year: 2022
  ident: e_1_3_6_12_1
  article-title: KASL clinical practice guidelines for management of chronic hepatitis B
  publication-title: Clin Mol Hepat
  doi: 10.3350/cmh.2022.0084
– ident: e_1_3_6_22_1
  doi: 10.1002/hep.27779
– ident: e_1_3_6_2_1
  doi: 10.1007/s12072-019-09946-3
– ident: e_1_3_6_10_1
  doi: 10.1016/S2468-1253(22)00050-4
– volume: 19
  start-page: 216
  issue: 3
  year: 2013
  ident: e_1_3_6_15_1
  article-title: KASL clinical practice guidelines: management of alcoholic liver disease
  publication-title: Clin Mol Hepatol
  doi: 10.3350/cmh.2013.19.3.216
– ident: e_1_3_6_26_1
  doi: 10.1097/MOG.0000000000000434
– ident: e_1_3_6_28_1
  doi: 10.1007/s10620-010-1390-3
– ident: e_1_3_6_11_1
  doi: 10.1016/S0140-6736(08)60383-9
SSID ssj0002710
Score 2.4628756
Snippet Acute decompensation (AD) is defined as the development of complications related to portal hypertension and liver dysfunction that affect the progression of...
Background/Aims Acute decompensation (AD) is defined as the development of complications related to portal hypertension and liver dysfunction that affect the...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 2428431
SubjectTerms acute decompensation
Acute-On-Chronic Liver Failure - epidemiology
Acute-On-Chronic Liver Failure - etiology
Acute-On-Chronic Liver Failure - mortality
Adult
aetiology
Aged
Chronic liver disease
Disease Progression
Female
Gastrointestinal Hemorrhage - etiology
Hepatitis, Viral, Human - complications
Hepatology
Humans
Hypertension, Portal - complications
Hypertension, Portal - etiology
liver cirrhosis
Liver Cirrhosis - etiology
Male
Middle Aged
Prognosis
Prospective Studies
Republic of Korea - epidemiology
Title Aetiology of chronic liver disease is a valuable factor for stratifying adverse outcomes of acute decompensation: prospective observational study
URI https://www.ncbi.nlm.nih.gov/pubmed/39856091
https://www.proquest.com/docview/3159796873
https://pubmed.ncbi.nlm.nih.gov/PMC11770857
https://doaj.org/article/44af5bcb5c5e450cb4a2f6cec739ad5e
Volume 57
WOSCitedRecordID wos001406236400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1365-2060
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002710
  issn: 0785-3890
  databaseCode: DOA
  dateStart: 20210101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVAWR
  databaseName: Taylor & Francis Open Access
  customDbUrl:
  eissn: 1365-2060
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002710
  issn: 0785-3890
  databaseCode: 0YH
  dateStart: 20210101
  isFulltext: true
  titleUrlDefault: https://www.tandfonline.com
  providerName: Taylor & Francis
– providerCode: PRVAWR
  databaseName: Taylor and Francis Online Journals
  customDbUrl:
  eissn: 1365-2060
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002710
  issn: 0785-3890
  databaseCode: TFW
  dateStart: 19890101
  isFulltext: true
  titleUrlDefault: https://www.tandfonline.com
  providerName: Taylor & Francis
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELWgQogL4pstUBmJa0o2tmOnt4KoeoCKA6DlFNmTsVipSqpulv_BP2bGTlZdhMSFSw6OlUw8Y89zZvxGiDeEoJlorOO0QSg0gi6a6OoiOqcN0JLoEu3it4_24sKtVs3nG6W-OCcs0wPngXurtY8mQDBgUJsSgvZVrAHBqsZ3Bnn1JdQzb6amNbiyiYeA_J8pyCWX89kdZtWmNm6ivWGlj8lDOa2We14pkff_DXH-mTh5wxOdPRD3JwgpT7PoD8Ut7B-Ju5-mIPlj8esUx3wIRQ5RQma_lZecgCGneIxcb6SXieg7XKLMRXck4VeZaXTT4SfpuVgzdR62I9klbvhxHrYjyg45FZ12wEmvJ5K-YT6yKYew-9FLUib62ifi69mHL-_Pi6nyQgHkscciWBsIqoCOlqPE4GrXlbpz1KIhNhyLc41jDsPaGFNrGwPYjtyh1wpVXaqn4qAfenwupG-07wAwEA7SpDS_xFiBQosIdbBxIY7nkW-vMsFGu5x5SydVtayqdlLVQrxj_ew6Mz92aiCraSeraf9lNQvxetZuS_OJgyS-x2G7aRXhO9vUzqqFeJa1vXuVahwBxIZEcHt2sCfL_p1-_SNxdnNsnIsJHP4P6V-IexWXIU5ZNS_FwXi9xVfiDvwc15vrI3G7_H5OV7tyR2lW_AasqhG3
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Aetiology+of+chronic+liver+disease+is+a+valuable+factor+for+stratifying+adverse+outcomes+of+acute+decompensation%3A+prospective+observational+study&rft.jtitle=Annals+of+medicine+%28Helsinki%29&rft.au=Kim%2C+Jung+Hee&rft.au=Kim%2C+Sung-Eun&rft.au=Song%2C+Do+Seon&rft.au=Kim%2C+Hee+Yeon&rft.date=2025-12-01&rft.pub=Taylor+%26+Francis&rft.issn=0785-3890&rft.eissn=1365-2060&rft.volume=57&rft.issue=1&rft_id=info:doi/10.1080%2F07853890.2024.2428431&rft_id=info%3Apmid%2F39856091&rft.externalDocID=PMC11770857
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0785-3890&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0785-3890&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0785-3890&client=summon